On the public citation graph

Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations

https://doi.org/10.3390/nu13093118
0 signed · 49 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/8904_2017_60openalex-snapshot
The Use of d2 and Benton Tests for Assessment of Attention Deficits and Visual Memory in Teenagers with Phenylketonuria
inferredcites →https://doi.org/10.1007/bf02312549openalex-snapshot
Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome
inferredcites →https://doi.org/10.1007/s00415-019-09608-2openalex-snapshot
Neurological manifestations in adults with phenylketonuria: new cases and review of the literature
inferredcites →https://doi.org/10.1016/j.ymgme.2007.05.006openalex-snapshot
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
inferredcites →https://doi.org/10.1016/j.ymgme.2011.08.023openalex-snapshot
Nutrition in phenylketonuria
inferredcites →https://doi.org/10.1016/j.ymgme.2013.08.013openalex-snapshot
Neurocognitive functioning in adults with phenylketonuria: Results of a long term study
inferredcites →https://doi.org/10.1016/j.ymgme.2017.01.001openalex-snapshot
Adherence to clinic recommendations among patients with phenylketonuria in the United States
inferredcites →https://doi.org/10.1016/j.ymgme.2019.04.004openalex-snapshot
International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria
inferredcites →https://doi.org/10.1016/s0140-6736(02)09334-0openalex-snapshot
How practical are recommendations for dietary control in phenylketonuria?
inferredcites →https://doi.org/10.1016/s2213-8587(17)30201-2openalex-snapshot
Issues with European guidelines for phenylketonuria
inferredcites →https://doi.org/10.1023/a:1020158631102openalex-snapshot
Phenylketonuria in adulthood: A collaborative study
inferredcites →https://doi.org/10.1037/neu0000336openalex-snapshot
The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
inferredcites →https://doi.org/10.1037/neu0000337openalex-snapshot
Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.
inferredcites →https://doi.org/10.1037/neu0000358openalex-snapshot
Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
inferredcites →https://doi.org/10.1038/ejcn.2016.54openalex-snapshot
Protein substitutes for phenylketonuria in Europe: access and nutritional composition
inferredcites →https://doi.org/10.1038/ejcn.2017.38openalex-snapshot
Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source
inferredcites →https://doi.org/10.1038/gim.2013.157openalex-snapshot
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
inferredcites →https://doi.org/10.1038/s41436-018-0403-zopenalex-snapshot
Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
inferredcites →https://doi.org/10.1186/s13023-015-0378-7openalex-snapshot
Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile
inferredcites →https://doi.org/10.1186/s13023-017-0685-2openalex-snapshot
The complete European guidelines on phenylketonuria: diagnosis and treatment
inferredcites →https://doi.org/10.1186/s13023-019-1011-yopenalex-snapshot
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
inferredcites →https://doi.org/10.1186/s13023-020-01391-yopenalex-snapshot
PKU dietary handbook to accompany PKU guidelines
inferredcites →https://doi.org/10.1186/s13023-020-1343-7openalex-snapshot
Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
inferredcites →https://doi.org/10.1186/s13023-021-01721-8openalex-snapshot
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
inferredcites →https://doi.org/10.1212/wnl.0000000000011088openalex-snapshot
Phenylalanine Effects on Brain Function in Adult Phenylketonuria
inferredcites →https://doi.org/10.1515/jpem-2018-0527openalex-snapshot
The European Phenylketonuria Guidelines and the challenges on management practices in Portugal
inferredcites →https://doi.org/10.3390/nu12113440openalex-snapshot
Protein Labelling Accuracy for UK Patients with PKU Following a Low Protein Diet
inferredcites →https://doi.org/10.3390/nu13020707openalex-snapshot
Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4094089openalex-extracted
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2026.37183openalex-snapshot
Longitudinal Metabolic Control in Children With Early-Treated Phenylketonuria
inferred← citeshttps://doi.org/10.1007/s00415-023-11703-4openalex-snapshot
Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion
inferred← citeshttps://doi.org/10.1016/j.clnu.2023.03.007openalex-snapshot
A food pyramid for adult patients with phenylketonuria and a systematic review on the current evidences regarding the optimal dietary treatment of adult patients with PKU
inferred← citeshttps://doi.org/10.1016/j.ymgme.2022.07.012openalex-snapshot
Management of Early Treated Adolescents and Young Adults with Phenylketonuria: Development of International Consensus Recommendations Using a Modified Delphi Approach
inferred← citeshttps://doi.org/10.1016/j.ymgme.2023.107564openalex-snapshot
Two years of pegvaliase in Germany: Experiences and best practice recommendations
inferred← citeshttps://doi.org/10.1177/10815589221143485openalex-snapshot
The role of phenylalanine levels in the neuropsychological and neuroanatomical status of adult patients with phenylketonuria: The impact of fluctuations
inferred← citeshttps://doi.org/10.1186/s13023-024-03203-zopenalex-snapshot
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria
inferred← citeshttps://doi.org/10.1186/s13023-026-04264-yopenalex-snapshot
Randomized investigation to evaluate phenylalanine fluctuation after overnight fasting in PKU patients treated with prolonged-release versus standard amino acid protein substitute
inferred← citeshttps://doi.org/10.20960/nh.04579openalex-snapshot
Dietary intake in individuals with phenylketonuria: an integrative review
inferred← citeshttps://doi.org/10.3345/cep.2022.00584openalex-snapshot
Protein substitutions as new-generation pharmanutrition approach to managing phenylketonuria
inferred← citeshttps://doi.org/10.3390/nu14051021openalex-snapshot
The Impact of the Quality of Nutrition and Lifestyle in the Reproductive Years of Women with PKU on the Long-Term Health of Their Children
inferred← citeshttps://doi.org/10.3390/nu14071355openalex-snapshot
The Challenges and Dilemmas of Interpreting Protein Labelling of Prepackaged Foods Encountered by the PKU Community
inferred← citeshttps://doi.org/10.3390/nu15133046openalex-snapshot
Preliminary Data on Free Use of Fruits and Vegetables Containing Phenylalanine 76–100 mg/100 g of Food in 16 Children with Phenylketonuria: 6 Months Follow-Up
inferred← citeshttps://doi.org/10.3390/nu15163603openalex-snapshot
Impact on Diet Quality and Burden of Care in Sapropterin Dihydrochloride Use in Children with Phenylketonuria: A 6 Month Follow-Up Report
inferred← citeshttps://doi.org/10.3390/nu15183940openalex-snapshot
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
inferred← citeshttps://doi.org/10.3390/nu15245133openalex-snapshot
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
inferred← citeshttps://doi.org/10.3390/nu16132064openalex-snapshot
Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
inferred← citeshttps://doi.org/10.6084/m9.figshare.26759459openalex-snapshot
Additional file 1 of Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria
inferred← citeshttps://doi.org/10.6084/m9.figshare.26759462openalex-snapshot
Additional file 2 of Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria
inferred← citeshttps://doi.org/10.6084/m9.figshare.26759465openalex-snapshot
Additional file 3 of Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.